These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19001931)

  • 41. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
    J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors related to driving in persons with an implantable cardioverter defibrillator.
    Craney JM; Powers MT
    Prog Cardiovasc Nurs; 1995; 10(3):12-7. PubMed ID: 7479657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. End-of-life decisions in ICD patients with malignant tumors.
    Kobza R; Erne P
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):845-9. PubMed ID: 17584265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States.
    Tsai V; Goldstein MK; Hsia HH; Wang Y; Curtis J; Heidenreich PA;
    Circ Cardiovasc Qual Outcomes; 2011 Sep; 4(5):549-56. PubMed ID: 21878667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
    de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Inactivation of the intracardial cardioverter/defibrillator (ICD) antitachycardial function in dilated cardiomyopathy. Driver can again work in her occupation].
    Laszlo R; Eick C; Schreieck J
    Dtsch Med Wochenschr; 2009 Jul; 134(31-32):1578-81. PubMed ID: 19629921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is it safe to drive with an automatic implantable cardioverter defibrillator or a history of recurrent symptomatic ventricular arrhythmias?
    Cambre S; Silverman ME
    Heart Dis Stroke; 1993; 2(3):179-81. PubMed ID: 8137022
    [No Abstract]   [Full Text] [Related]  

  • 50. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6.
    Proclemer A; Ghidina M; Facchin D; Rebellato L; Corrado D; Gasparini M; Gregori D
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):434-45. PubMed ID: 19335851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004.
    Proclemer A; Ghidina M; Cicuttini G; Gregori D; Fioretti PM
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S20-8. PubMed ID: 17169129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of wireless capsule endoscopy in patients with implantable cardiac defibrillators.
    Leighton JA; Srivathsan K; Carey EJ; Sharma VK; Heigh RI; Post JK; Erickson PJ; Robinson SR; Bazzell JL; Fleischer DE
    Am J Gastroenterol; 2005 Aug; 100(8):1728-31. PubMed ID: 16086708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The quick-implantable-defibrillator trial.
    Bänsch D; Kottkamp H; Grönefeld G; Vogt J; Israel C; Böcker D; Hindricks G; Kuck KH;
    Europace; 2007 Dec; 9(12):1144-50. PubMed ID: 17913695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Rhythm ID Going Head to Head Trial (RIGHT): design of a randomized trial comparing competitive rhythm discrimination algorithms in implantable cardioverter defibrillators.
    Berger RD; Lerew DR; Smith JM; Pulling C; Gold MR
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):749-53. PubMed ID: 16836672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The psychological impact of implantable cardioverter defibrillator implantation on Brugada syndrome patients.
    Probst V; Plassard-Kerdoncuf D; Mansourati J; Mabo P; Sacher F; Fruchet C; Babuty D; Lande G; Guyomarc'h B; Le Marec H
    Europace; 2011 Jul; 13(7):1034-9. PubMed ID: 21427091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
    Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
    Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.